(S)-2-(Boc-Amino)non-8-Enoic Acid CAS 300831-21-4 Purity >98.0% (GC) ee >99.0% Paritaprevir Intermediate Factory
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-2-(Boc-Amino)non-8-Enoic Acid (CAS: 300831-21-4) with high quality, commercial production. Ruifu Chemical offers a wide range of chiral compounds. We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Gemyske namme | (S)-2-(Boc-Amino)non-8-Enoic Acid |
Synonimen | (S)-2-(tert-Butoxycarbonylamino)non-8-Enoic acid;(S)-2-(Boc-Amino)-8-Nonenoic acid;(2S)-2-[(2-Methylpropan-2-yl)oxycarbonylamino]non-8-Enoic acid;(2S)-2-{[(tert-Butoksy)karbonyl]amino}non-8-Enoic acid |
CAS nûmer | 300831-21-4 |
CAT nûmer | RF-CC347 |
Stock Status | Op foarrie |
Molekulêre formule | C14H25NO4 |
Molekuul gewicht | 271.35 |
Tichtheid | 1,035±0,06 g/cm3 |
Merk | It bedriuw Ruifu Chemical |
Ûnderdiel | Spesifikaasjes |
Ferskining | Brune floeistof |
Purity / Analyse metoade | >98.0% (GC) |
ee | >99.0% |
Test Standert | Enterprise Standert |
Gebrûk | Tussenprodukten fan Paritaprevir (CAS: 1216941-48-8) |
Pakket: Fluorinated Bottle, 25kg / Drum, of neffens klant syn eask
Opslach betingst:Bewarje yn fersegele konteners op in koel en droech plak;Beskermje fan ljocht en focht


(S)-2-(Boc-Amino)non-8-Enoic Acid (CAS: 300831-21-4) kin brûkt wurde as in intermediate yn 'e synteze fan Paritaprevir (CAS: 1216941-48-8) en besibbe analogen.Paritaprevir is in twadde-generaasje NS3 / 4A protease-ynhibitor, is in komponint fan 'e all-orale, interferon-frije hepatitis C-firus-kombinaasje-terapy ûntwikkele troch Enanta Pharmaceuticals en AbbVie.De tablet mei fêste doses fan Paritaprevir, Ombitasvir en Ritonavir nommen yn kombinaasje mei Dasabuvir waard goedkard foar de behanneling fan chronike HCV genotype 1 yn 'e FS en EU yn 2014, en fierder goedkard foar behanneling fan genotype 4 chronike HCV-ynfeksje sûnder cirrhosis troch de FS. FDA yn 2015.
-
(S)-2-(Boc-Amino)non-8-Enoic Acid CAS 300831-21...
-
(S)-2-(benzyloksy)propanoic acid CAS 33106-32-0 ...
-
(S)-2-(Methoxymethyl)pyrrolidine CAS 63126-47-6...
-
(S)-2-Amino-1,1,1-Trifluorpropane Hydrochloride...
-
(S)-2-Aminobutyramide Hydrochloride CAS 7682-20...
-
(S)-2-Hydroxy-3-Methoxy-3,3-Diphenylpropionic A...
-
(S)-2-Hydroxy-3-Methylbutanoic Acid CAS 17407-5...
-
(S)-2-Hydroxybutyric Acid CAS 3347-90-8 Purity ...
-
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrroli...
-
(S)-(-)-2-Acetoxypropionzuur CAS 6034-46-4 P...
-
(S)-(-)-2-Bromo-3-Hydroxypropanoic Acid CAS 706...
-
(S)-(-)-2-Bromopropionzuur CAS 32644-15-8 Pu...
-
(S)-(-)-2-Chloropropionzuur CAS 29617-66-1 A...
-
(S)-(-)-2-methyl-CBS-oxazaborolidine;(S)-Me-CB...
-
(S)-(-)-2-Methylbutanol CAS 1565-80-6 Suverens >9...
-
Methyl (S)-(-)-2-Chloorpropionate CAS 73246-45-...